• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Curavi Acquires Post-Acute Telemedicine Provider Platform TripleCare

by Fred Pennic 12/04/2018 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

 Curavi Acquires Post-Acute Telemedicine Provider Platform TripleCare

Curavi Health Inc., a comprehensive telemedicine solution for the nursing home today announced the acquisition of TripleCare, a Long Island City, New York-based provider of telemedicine solutions for the post-acute, long-term care industry, including skilled nursing facilities. For Curavi, the acquisition positions itself as a leader in the telemedicine market for the post-acute care space.

Triple Care Overview

Similar to Curavi, TripleCare uses a comprehensive telemedicine platform to give residents at post-acute facilities access to physicians at times when they are not readily available, such as on weekends, overnight and holidays. The technology allows residents to be treated in place, from the comfort of their bedside, often avoiding unnecessary visits to emergency rooms or hospitalizations. Such transfers can be disruptive to residents and sometimes harmful to their health while costing Medicare and other payors billions of dollars a year.  To date, TripleCare physicians have cared for thousands of patients in 50 facilities and helped skilled nursing homes avoid unnecessary hospital transfers and admissions more than 80 percent of the time.

Once the acquisition is closed, the combined entity will serve nearly 100 facilities across 14 states. Meade will continue as CEO of the combined company, while TripleCare’s interim CEO, Mary Jo Gorman, M.D., will assume a newly established seat on Curavi’s board of directors. Leslie C. Davis, senior vice president of UPMC and executive vice president and chief operating officer of the Health Services Division, is also being added to the board.

Founded in 2016, Curavi spun out of UPMC and currently serves more than 40 facilities in three states with general and specialty care, after-hours coverage, geriatric psychiatry consultations and “bring your own provider” solutions that allow nursing homes to use their own attending physicians and nurse practitioners for telemedicine consults. Curavi developed its hardware and software to fit the workflow of the demanding nursing home environment.

“By combining the strengths of these two telemedicine leaders in the post-acute care industry, the facilities and residents we serve will have access to the highest-quality care and most innovative telemedicine technology,” said Alissa Meade, Curavi’s president and chief executive officer. “We look forward to growing our services by integrating TripleCare’s strong network and seasoned team into Curavi Health.”

 

Financial details of the acquisition were not disclosed. 

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Healthcare Mergers & Acquisitions

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |